Predictors of Health-related Quality of Life and Adjustment to Prostate Cancer During Active Surveillance

被引:78
作者
Bellardita, Lara [1 ]
Rancati, Tiziana [1 ]
Alvisi, Maria Francesca [1 ]
Villani, Daniela [2 ]
Magnani, Tiziana [1 ]
Marenghi, Cristina [1 ]
Nicolai, Nicola [3 ]
Procopio, Giuseppe [4 ]
Villa, Sergio [5 ]
Salvioni, Roberto [3 ]
Valdagni, Riccardo [1 ,5 ]
机构
[1] Fdn IRCCS Ist Nazl Tumori, Prostate Canc Program, I-20133 Milan, Italy
[2] Catholic Univ, Dept Psychol, Milan, Italy
[3] Fdn IRCCS Ist Nazl Tumori, Urol Unit, I-20133 Milan, Italy
[4] Fdn IRCCS Ist Nazl Tumori, Oncol Unit, I-20133 Milan, Italy
[5] Fdn IRCCS Ist Nazl Tumori, I-20133 Milan, Italy
关键词
Active surveillance; Adjustment to cancer; Coping; Quality of life; Prostate cancer; MENTAL ADJUSTMENT; ANXIETY; DEPRESSION;
D O I
10.1016/j.eururo.2013.01.009
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background: Active surveillance (AS) is emerging as an alternative approach to limit the risk of overtreatment and impairment of quality of life (QoL) in patients with low-risk localised prostate cancer. Although most patients report high levels of QoL, some men may be distressed by the idea of living with untreated cancer. Objective: To identify factors associated with poor QoL during AS. Design, setting, and participants: Between September 2007 and March 2012, 103 patients participated in the Prostate Cancer Research International Active Surveillance (PRIAS) QoL study. Mental health (Symptom Checklist-90), demographic, clinical, and decisional data were assessed at entrance in AS. Health-related QoL (HRQoL) Functional Assessment of Cancer Therapy-Prostate version and Mini-Mental Adjustment to Cancer outcomes were assessed after 10 mo of AS. Outcome measurements and statistical analysis: Multivariate logistic regression models were used to identify predictors of low (<25th percentile) HRQoL, adjustment to cancer, and a global QoL index at 10 mo after enrolment. Results and limitations: The mean age of the study patients was 67 yr (standard deviation: +/- 7 yr). Lack of partner (odds ratio [OR]: 0.08; p = 0.009) and impaired mental health (OR: 1.2, p = 0.1) were associated with low HRQoL (p = 0.006; area under the curve [AUC]: 0.72). The maladaptive adjustment to cancer (p = 0.047; AUC: 0.60) could be predicted by recent diagnosis (OR: 3.3; p = 0.072). Poor global QoL (overall p = 0.02; AUC: 0.85) was predicted by impaired mental health (OR: 1.16; p = 0.070) and time from diagnosis to enrolment in AS <5 mo (OR: 5.52; p = 0.009). Influence of different physicians on the choice of AS (OR: 0.17; p = 0.044), presence of a partner (OR: 0.22; p = 0.065), and diagnostic biopsy with >18 core specimens (OR: 0.89; p = 0.029) were predictors of better QoL. Limitations of this study were the small sample size and the lack of a control group. Conclusions: Factors predicting poor QoL were lack of a partner, impaired mental health, recent diagnosis, influence of clinicians and lower number of core samples taken at diagnostic biopsy. Educational support from physicians and emotional/social support should be promoted in some cases to prevent poor QoL. (C) 2013 European Association of Urology. Published by Elsevier B. V. All rights reserved.
引用
收藏
页码:30 / 36
页数:7
相关论文
共 30 条
[1]   STANDARDIZED TOTAL AVERAGE TOXICITY SCORE: A SCALE- AND GRADE-INDEPENDENT MEASURE OF LATE RADIOTHERAPY TOXICITY TO FACILITATE POOLING OF DATA FROM DIFFERENT STUDIES [J].
Barnett, Gillian C. ;
West, Catharine M. L. ;
Coles, Charlotte E. ;
Pharoah, Paul D. P. ;
Talbot, Christopher J. ;
Elliott, Rebecca M. ;
Tanteles, George A. ;
Symonds, R. Paul ;
Wilkinson, Jennifer S. ;
Dunning, Alison M. ;
Burnet, Neil G. ;
Bentzen, Soren M. .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012, 82 (03) :1065-1074
[2]  
Bellardita L., 2012, NEUROPSYCHOL TRENDS, V12, P107, DOI [DOI 10.7358/NEUR-2012-012-BELL, 10.7358/neur-2012-012-bell]
[3]  
Bellardita L, 2012, 27 ANN C EUR ASS UR
[4]   THE INTERNATIONAL PROSTATE SYMPTOM SCORE IN A COMMUNITY-BASED SAMPLE OF MEN BETWEEN 55 AND 74 YEARS OF AGE - PREVALENCE AND CORRELATION OF SYMPTOMS WITH AGE, PROSTATE VOLUME, FLOW-RATE AND RESIDUAL URINE VOLUME [J].
BOSCH, JLHR ;
HOP, WCJ ;
KIRKELS, WJ ;
SCHRODER, FH .
BRITISH JOURNAL OF UROLOGY, 1995, 75 (05) :622-630
[5]   Does active surveillance for men with localized prostate cancer carry psychological morbidity? [J].
Burnet, Katriina L. ;
Parker, Chris ;
Dearnaley, David ;
Brewin, Chris R. ;
Watson, Maggie .
BJU INTERNATIONAL, 2007, 100 (03) :540-543
[6]   Estimating Clinically Meaningful Changes for the Functional Assessment of Cancer Therapy-Prostate: Results from a Clinical Trial of Patients with Metastatic Hormone-Refractory Prostate Cancer [J].
Cella, David ;
Nichol, Michael B. ;
Eton, David ;
Nelson, Joel B. ;
Mulani, Parvez .
VALUE IN HEALTH, 2009, 12 (01) :124-129
[7]   International Variation in Prostate Cancer Incidence and Mortality Rates [J].
Center, Melissa M. ;
Jemal, Ahmedin ;
Lortet-Tieulent, Joannie ;
Ward, Elizabeth ;
Ferlay, Jacques ;
Brawley, Otis ;
Bray, Freddie .
EUROPEAN UROLOGY, 2012, 61 (06) :1079-1092
[8]   Active Surveillance for Prostate Cancer: Progress and Promise [J].
Cooperberg, Matthew R. ;
Carroll, Peter R. ;
Klotz, Laurence .
JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (27) :3669-3676
[9]   Active Surveillance for Prostate Cancer: A Systematic Review of the Literature [J].
Dall'Era, Marc A. ;
Albertsen, Peter C. ;
Bangma, Christopher ;
Carroll, Peter R. ;
Carter, H. Ballentine ;
Cooperberg, Matthew R. ;
Freedland, Stephen J. ;
Klotz, Laurence H. ;
Parker, Christopher ;
Soloway, Mark S. .
EUROPEAN UROLOGY, 2012, 62 (06) :976-983
[10]  
Derogatis L.R., 1997, SCL-90-R Administration scoring and procedures manual -1-